Fundies. English
Segment disclosures
Company overviewIDEXX LABORATORIES INC /DE
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
82 dimension combinations 759 retained observations 27 reported periods Partial retained history
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · CAG Diagnostic Capital Instruments · Companion Animal Group Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=idxx:CAGDiagnosticCapitalInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 42449000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 200206000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 51479000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 142073000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 58600000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 90594000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 31994000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 131928000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 29528000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 98912000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 35292000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 69384000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 34092000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 137603000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 147326000 | USD | 20250221 | Open filing evidence |
Operating Segments · CAG Diagnostics Recurring Revenue · Companion Animal Group Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=idxx:CAGDiagnosticsRecurringRevenueMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 920313000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 3407199000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 873273000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2557535000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 877995000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1684262000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 806267000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3129492000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 783443000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2372041000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 808454000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1588598000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 780144000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2935425000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2660280000 | USD | 20250221 | Open filing evidence |
Operating Segments · CAG Diagnostics Service And Accessories · Companion Animal Group Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=idxx:CAGDiagnosticsServiceAndAccessoriesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 36614000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 137424000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 34097000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 102094000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 34949000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 67997000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 33048000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 130367000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 33158000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 98163000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 32443000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 65005000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 32562000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 124053000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 111264000 | USD | 20250221 | Open filing evidence |
Operating Segments · Rapid Assay Products · Companion Animal Group Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=idxx:RapidAssayProductsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 84938000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 348950000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 88638000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 272912000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 100240000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 184274000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 84034000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 359754000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 92774000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 282379000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 103290000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 189605000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 86315000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 344494000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 313667000 | USD | 20250221 | Open filing evidence |
Operating Segments · Recurring Revenue · Companion Animal Group Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=idxx:RecurringRevenueMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 73536000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 276338000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 70988000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 205735000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 68954000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 134747000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 65793000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 250359000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 64644000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 187461000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 63117000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 122817000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 59700000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 214597000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 180973000 | USD | 20250221 | Open filing evidence |
Operating Segments · Reference Laboratory Diagnostic And Consulting Services · Companion Animal Group Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 386179000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1424073000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 362725000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1074825000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 367694000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 712100000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 344406000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1336121000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 328383000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1020094000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 347373000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 691711000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 344338000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1278617000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1178113000 | USD | 20250221 | Open filing evidence |
Operating Segments · Systems And Hardware · Companion Animal Group Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=idxx:SystemsAndHardwareMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 17754000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 69542000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 16794000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 49470000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 16894000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 32676000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 15782000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 62265000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 14375000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 45159000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 15435000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 30784000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 15349000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 64731000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 70214000 | USD | 20250221 | Open filing evidence |
Operating Segments · Veterinary Software Services And Diagnostic Imaging Systems · Companion Animal Group Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 91290000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 345880000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 87782000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 255205000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 85848000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 167423000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 81575000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 312624000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 79019000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 232620000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 78552000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 153601000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 75049000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 279328000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 251187000 | USD | 20250221 | Open filing evidence |
Operating Segments · Vet Lab Consumables · Companion Animal Group Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=idxx:VetLabConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 412582000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1496752000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 387813000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1107704000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 375112000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 719891000 | USD | 20250804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 344779000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1303250000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 329128000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 971405000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 325348000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 642277000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 316929000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1188261000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1057236000 | USD | 20250221 | Open filing evidence |
Operating Segments · Cag Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 566100000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 1118096000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 551996000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 2119183000 | USD | 20200214 | Open filing evidence |
Operating Segments · CAG Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CAGSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 2385765000 | USD | 20210212 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 2119183000 | USD | 20210212 | Open filing evidence |
Operating Segments · Companion Animal Group Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1118236000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 2172288000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1054052000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 3953285000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1012534000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2954813000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1022443000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1942279000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 919836000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3574044000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 891990000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2703573000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 922298000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1811583000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 889285000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3352356000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3058793000 | USD | 20250221 | Open filing evidence |
Operating Segments · Livestock And Poultry Diagnostics Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:LivestockAndPoultryDiagnosticsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 35181000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 67664000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 32483000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 131787000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 33944000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 94302000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 31762000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 60358000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 28596000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 122060000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 28992000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 87503000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 30306000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 58511000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 28205000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 121659000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 122607000 | USD | 20250221 | Open filing evidence |
Operating Segments · Lpd Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:LpdSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 36971000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 103369000 | USD | 20201029 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 32244000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 66398000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 34154000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 132635000 | USD | 20200214 | Open filing evidence |
Operating Segments · LPD Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:LPDSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 145845000 | USD | 20210212 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 132635000 | USD | 20210212 | Open filing evidence |
Operating Segments · Other Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:OtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 46420000 | USD | 20210212 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 11132000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 17169000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 6037000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 22240000 | USD | 20210212 | Open filing evidence |
Operating Segments · Water Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:WaterSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 58564000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 108829000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 50265000 | USD | 20260505 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 201149000 | USD | 20260220 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 54297000 | USD | 20251103 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 150619000 | USD | 20251103 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 51001000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 96322000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 45321000 | USD | 20260505 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 185112000 | USD | 20260220 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 50162000 | USD | 20251103 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 139959000 | USD | 20251103 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 46726000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 89797000 | USD | 20250804 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 43071000 | USD | 20250501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 168149000 | USD | 20260220 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 155720000 | USD | 20250221 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 128625000 | USD | 20210212 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 33272000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 95537000 | USD | 20201029 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 28116000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 62265000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 34149000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 132850000 | USD | 20210212 | Open filing evidence |
CAG Diagnostic Capital Instruments · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CAGDiagnosticCapitalInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 29528000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 98912000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 35292000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 69384000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 34092000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 137603000 | USD | 20240222 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 32254000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 99452000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 34054000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 67198000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 33144000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 147326000 | USD | 20240222 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 149140000 | USD | 20240222 | Open filing evidence |
CAG Diagnostic Capital Instruments · Companion Animal Group Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=idxx:CAGDiagnosticCapitalInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 47174000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 89623000 | USD | 20260804 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 58600000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 90594000 | USD | 20260804 | Open filing evidence |
CAG Diagnostic Capital Vetlab Instruments · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CAGDiagnosticCapitalVetlabInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 147326000 | USD | 20230216 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 149140000 | USD | 20230216 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 108950000 | USD | 20230216 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 132685000 | USD | 20220216 | Open filing evidence |
Cag Diagnostic Captail Vetlab Instruments · Cag Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CagDiagnosticCaptailVetlabInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 36227000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 73224000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 36997000 | USD | 20220504 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 39401000 | USD | 20211102 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 105645000 | USD | 20211102 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 35054000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 66244000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 31190000 | USD | 20220504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 29336000 | USD | 20211102 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 72040000 | USD | 20211102 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 18871000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 42704000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 23833000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 132685000 | USD | 20200214 | Open filing evidence |
Cag Diagnostic Captail Vetlab Instruments · CAG Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CagDiagnosticCaptailVetlabInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CAGSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 108950000 | USD | 20210212 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 132685000 | USD | 20210212 | Open filing evidence |
Cag Diagnostic Captail Vetlab Instruments · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CagDiagnosticCaptailVetlabInstrumentsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 34054000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 67198000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 33144000 | USD | 20230502 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 36227000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 73224000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 36997000 | USD | 20230502 | Open filing evidence |
Cag Diagnostics Recurring Revenue · Cag Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CagDiagnosticsRecurringRevenueMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 685413000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1350223000 | USD | 20220802 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 638358000 | USD | 20211102 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1916938000 | USD | 20211102 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 661300000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 1278580000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 617280000 | USD | 20210504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 567416000 | USD | 20211102 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1565595000 | USD | 20211102 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 510254000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 998179000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 487925000 | USD | 20210504 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1828329000 | USD | 20200214 | Open filing evidence |
Cag Diagnostics Recurring Revenue · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CagDiagnosticsRecurringRevenueMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 726902000 | USD | 20230502 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 664810000 | USD | 20230502 | Open filing evidence |
CAG Diagnostics Recurring Revenue · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CAGDiagnosticsRecurringRevenueMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 783443000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2372041000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 808454000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1588598000 | USD | 20240806 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 733958000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2223336000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 762476000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1489378000 | USD | 20240806 | Open filing evidence |
CAG Diagnostics Recurring Revenue · Companion Animal Group Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=idxx:CAGDiagnosticsRecurringRevenueMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 974713000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1895026000 | USD | 20260804 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 877995000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1684262000 | USD | 20260804 | Open filing evidence |
Cag Diagnostics Service And Accessories · Cag Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CagDiagnosticsServiceAndAccessoriesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 27723000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 55766000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 28043000 | USD | 20220504 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 26369000 | USD | 20211102 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 79551000 | USD | 20211102 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 27386000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 53182000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 25796000 | USD | 20220504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 23995000 | USD | 20211102 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 66235000 | USD | 20211102 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 20719000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 42240000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 21521000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 80323000 | USD | 20200214 | Open filing evidence |
Cag Diagnostics Service And Accessories · CAG Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CagDiagnosticsServiceAndAccessoriesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CAGSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 90177000 | USD | 20210212 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 80323000 | USD | 20210212 | Open filing evidence |
Cag Diagnostics Service And Accessories · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CagDiagnosticsServiceAndAccessoriesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 30060000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 91931000 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 31295000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 61871000 | USD | 20230801 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 28357000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 84123000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 27723000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 55766000 | USD | 20230801 | Open filing evidence |
CAG Diagnostics Service And Accessories · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:CAGDiagnosticsServiceAndAccessoriesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 33158000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 98163000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 32443000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 65005000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 32562000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 124053000 | USD | 20240222 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 30060000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 91931000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 31295000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 61871000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 30576000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 111264000 | USD | 20240222 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 107273000 | USD | 20240222 | Open filing evidence |
CAG Diagnostics Service And Accessories · Companion Animal Group Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=idxx:CAGDiagnosticsServiceAndAccessoriesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 36072000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 72686000 | USD | 20260804 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 34949000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 67997000 | USD | 20260804 | Open filing evidence |
Rapid Assay Products · Cag Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:RapidAssayProductsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 87481000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 162000000 | USD | 20220802 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 76974000 | USD | 20211102 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 230472000 | USD | 20211102 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 83887000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 153498000 | USD | 20220802 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 70593000 | USD | 20211102 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 192681000 | USD | 20211102 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 64658000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 122088000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 57430000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 232149000 | USD | 20200214 | Open filing evidence |
Rapid Assay Products · CAG Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:RapidAssayProductsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CAGSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 253018000 | USD | 20210212 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 232149000 | USD | 20210212 | Open filing evidence |
Rapid Assay Products · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:RapidAssayProductsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 92774000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 282379000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 103290000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 189605000 | USD | 20240806 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 87562000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 266934000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 97340000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 179372000 | USD | 20240806 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 313667000 | USD | 20230216 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 296852000 | USD | 20230216 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 253018000 | USD | 20230216 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 232149000 | USD | 20220216 | Open filing evidence |
Rapid Assay Products · Companion Animal Group Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=idxx:RapidAssayProductsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 101575000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 186513000 | USD | 20260804 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 100240000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 184274000 | USD | 20260804 | Open filing evidence |
Recurring Revenue · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:RecurringRevenueMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 64644000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 187461000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 63117000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 122817000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 59700000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 214597000 | USD | 20240222 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 54607000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 160039000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 53725000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 105432000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 51707000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 180973000 | USD | 20240222 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 147498000 | USD | 20240222 | Open filing evidence |
Recurring Revenue · Companion Animal Group Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=idxx:RecurringRevenueMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 76343000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 149879000 | USD | 20260804 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 68954000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 134747000 | USD | 20260804 | Open filing evidence |
Reference Laboratory Diagnostic And Consulting Services · Cag Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 304130000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 599205000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 295075000 | USD | 20220504 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 282301000 | USD | 20211102 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 851757000 | USD | 20211102 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 293675000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 569456000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 275781000 | USD | 20220504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 254223000 | USD | 20211102 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 703300000 | USD | 20211102 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 228816000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 449077000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 220261000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 822497000 | USD | 20200214 | Open filing evidence |
Reference Laboratory Diagnostic And Consulting Services · CAG Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CAGSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 946268000 | USD | 20210212 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 822497000 | USD | 20210212 | Open filing evidence |
Reference Laboratory Diagnostic And Consulting Services · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 328383000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1020094000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 347373000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 691711000 | USD | 20240806 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 320294000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 973580000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 330106000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 653286000 | USD | 20240806 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1178113000 | USD | 20230216 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 304130000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 599205000 | USD | 20230801 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1123656000 | USD | 20230216 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 946268000 | USD | 20230216 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 822497000 | USD | 20220216 | Open filing evidence |
Reference Laboratory Diagnostic And Consulting Services · Companion Animal Group Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 406729000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 792908000 | USD | 20260804 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 367694000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 712100000 | USD | 20260804 | Open filing evidence |
Systems And Hardware · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:SystemsAndHardwareMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 14375000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 45159000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 15435000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 30784000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 64731000 | USD | 20240222 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 16341000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 48264000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 16397000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 31923000 | USD | 20240806 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 70214000 | USD | 20240222 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 58760000 | USD | 20240222 | Open filing evidence |
Systems And Hardware · Companion Animal Group Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=idxx:SystemsAndHardwareMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 20006000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 37760000 | USD | 20260804 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 16894000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 32676000 | USD | 20260804 | Open filing evidence |
Veterinary Software Services And Diagnostic Imaging Systems · Cag Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 62447000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 121824000 | USD | 20220802 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 54736000 | USD | 20211102 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 148274000 | USD | 20211102 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 49241000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 93538000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 44297000 | USD | 20210504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 41265000 | USD | 20211102 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 118478000 | USD | 20211102 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 36975000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 77213000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 40238000 | USD | 20210504 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 158169000 | USD | 20200214 | Open filing evidence |
Veterinary Software Services And Diagnostic Imaging Systems · CAG Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CAGSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 162976000 | USD | 20210212 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 158169000 | USD | 20210212 | Open filing evidence |
Veterinary Software Services And Diagnostic Imaging Systems · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 79019000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 232620000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 78552000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 153601000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 75049000 | USD | 20240501 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 70948000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 208303000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 70122000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 137355000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 67233000 | USD | 20240501 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 62505000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 184329000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 62447000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 121824000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 59377000 | USD | 20230502 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 206258000 | USD | 20220216 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 162976000 | USD | 20220216 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 158169000 | USD | 20220216 | Open filing evidence |
Veterinary Software Services And Diagnostic Imaging Systems · Companion Animal Group Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 96349000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 187639000 | USD | 20260804 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 85848000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 167423000 | USD | 20260804 | Open filing evidence |
Vetlab Consumables · Cag Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:VetlabConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 266079000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 533252000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 267173000 | USD | 20220504 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 252714000 | USD | 20211102 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 755158000 | USD | 20211102 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 256352000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 502444000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 246092000 | USD | 20220504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 218605000 | USD | 20211102 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 603379000 | USD | 20211102 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 196061000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 384774000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 188713000 | USD | 20200430 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 693360000 | USD | 20200214 | Open filing evidence |
Vetlab Consumables · CAG Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:VetlabConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CAGSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 824376000 | USD | 20210212 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 693360000 | USD | 20210212 | Open filing evidence |
Vetlab Consumables · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:VetlabConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 303735000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 594849000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 291114000 | USD | 20230502 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 266079000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 533252000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 267173000 | USD | 20230502 | Open filing evidence |
Vet Lab Consumables · Companion Animal Group Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=idxx:VetLabConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 329128000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 971405000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 325348000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 642277000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1188261000 | USD | 20240222 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 296042000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 890891000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 303735000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 594849000 | USD | 20240806 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1057236000 | USD | 20240222 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1006781000 | USD | 20240222 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 824376000 | USD | 20220216 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 693360000 | USD | 20220216 | Open filing evidence |
Vet Lab Consumables · Companion Animal Group Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=idxx:VetLabConsumablesMember;us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 430337000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 842919000 | USD | 20260804 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 375112000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 719891000 | USD | 20260804 | Open filing evidence |
Cag Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 764990000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2310261000 | USD | 20221101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 784087000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1545271000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 761184000 | USD | 20220504 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 732495000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 2170857000 | USD | 20221101 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 745595000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 1438362000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 692767000 | USD | 20220504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 638017000 | USD | 20211102 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1756113000 | USD | 20211102 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 566100000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 1118096000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 551996000 | USD | 20210504 | Open filing evidence |
CAG Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CAGSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 2385765000 | USD | 20210212 | Open filing evidence |
Cag Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 638017000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1756113000 | USD | 20201029 | Open filing evidence |
Cag Segment · Cag Diagnostic Captail Vetlab Instruments
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember;srt:ProductOrServiceAxis=idxx:CagDiagnosticCaptailVetlabInstrumentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 35176000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 108400000 | USD | 20221101 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 39401000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 105645000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 31190000 | USD | 20210504 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 23833000 | USD | 20210504 | Open filing evidence |
Cag Segment · Cag Diagnostics Recurring Revenue
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember;srt:ProductOrServiceAxis=idxx:CagDiagnosticsRecurringRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 667309000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2017532000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 664810000 | USD | 20220504 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 638358000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1916938000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 617280000 | USD | 20220504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 567416000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 1565595000 | USD | 20201029 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 510254000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 998179000 | USD | 20200731 | Open filing evidence |
CAG Segment · Cag Diagnostics Recurring Revenue
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CAGSegmentMember;srt:ProductOrServiceAxis=idxx:CagDiagnosticsRecurringRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 2113839000 | USD | 20210212 | Open filing evidence |
Cag Segment · Cag Diagnostics Service And Accessories
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember;srt:ProductOrServiceAxis=idxx:CagDiagnosticsServiceAndAccessoriesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 28357000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 84123000 | USD | 20221101 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 26369000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 79551000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 25796000 | USD | 20210504 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 20719000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 42240000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 21521000 | USD | 20210504 | Open filing evidence |
Cag Segment · Rapid Assay Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember;srt:ProductOrServiceAxis=idxx:RapidAssayProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 80542000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 242542000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 74519000 | USD | 20220504 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 76974000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 230472000 | USD | 20221101 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 83887000 | USD | 20210730 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 153498000 | USD | 20210730 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 69611000 | USD | 20220504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 70593000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 192681000 | USD | 20201029 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 64658000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 122088000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 57430000 | USD | 20210504 | Open filing evidence |
Cag Segment · Reference Laboratory Diagnostic And Consulting Services
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember;srt:ProductOrServiceAxis=idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 295590000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 894795000 | USD | 20221101 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 282301000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 851757000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 275781000 | USD | 20210504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 254223000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 703300000 | USD | 20201029 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 228816000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 449077000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 220261000 | USD | 20210504 | Open filing evidence |
Cag Segment · Veterinary Software Services And Diagnostic Imaging Systems
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember;srt:ProductOrServiceAxis=idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 62505000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 184329000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 59377000 | USD | 20220504 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 54736000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 148274000 | USD | 20221101 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 49241000 | USD | 20210730 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 93538000 | USD | 20210730 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 44297000 | USD | 20220504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 41265000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 118478000 | USD | 20201029 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 36975000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 77213000 | USD | 20210730 | Open filing evidence |
Cag Segment · Vetlab Consumables
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CagSegmentMember;srt:ProductOrServiceAxis=idxx:VetlabConsumablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 262820000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 796072000 | USD | 20221101 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 252714000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 755158000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 246092000 | USD | 20210504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 218605000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 603379000 | USD | 20201029 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 196061000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 384774000 | USD | 20200731 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 188713000 | USD | 20210504 | Open filing evidence |
Companion Animal Group Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 891990000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2703573000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 922298000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1811583000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 889285000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3352356000 | USD | 20240222 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 837160000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2531091000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 866652000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1693931000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 827279000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 3058793000 | USD | 20240222 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 764990000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2310261000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 784087000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1545271000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 761184000 | USD | 20230502 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2889960000 | USD | 20240222 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 2385765000 | USD | 20230216 | Open filing evidence |
Companion Animal Group Segment · Cag Diagnostic Captail Vetlab Instruments
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ProductOrServiceAxis=idxx:CagDiagnosticCaptailVetlabInstrumentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 32254000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 99452000 | USD | 20231101 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 35176000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 108400000 | USD | 20231101 | Open filing evidence |
Companion Animal Group Segment · Cag Diagnostics Recurring Revenue
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ProductOrServiceAxis=idxx:CagDiagnosticsRecurringRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 733958000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2223336000 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 762476000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1489378000 | USD | 20230801 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 667309000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 2017532000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 685413000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1350223000 | USD | 20230801 | Open filing evidence |
Companion Animal Group Segment · CAG Diagnostics Recurring Revenue
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ProductOrServiceAxis=idxx:CAGDiagnosticsRecurringRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 780144000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2935425000 | USD | 20240222 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 726902000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 2660280000 | USD | 20240222 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2534562000 | USD | 20240222 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 2113839000 | USD | 20230216 | Open filing evidence |
Companion Animal Group Segment · Cag Diagnostics Service And Accessories
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ProductOrServiceAxis=idxx:CagDiagnosticsServiceAndAccessoriesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 30576000 | USD | 20230502 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 28043000 | USD | 20230502 | Open filing evidence |
Companion Animal Group Segment · CAG Diagnostics Service And Accessories
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ProductOrServiceAxis=idxx:CAGDiagnosticsServiceAndAccessoriesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 111264000 | USD | 20230216 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 107273000 | USD | 20230216 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 90177000 | USD | 20230216 | Open filing evidence |
Companion Animal Group Segment · Rapid Assay Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ProductOrServiceAxis=idxx:RapidAssayProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 86315000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 344494000 | USD | 20240222 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 87562000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 266934000 | USD | 20231101 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 97340000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 179372000 | USD | 20230801 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 82032000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 313667000 | USD | 20240222 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 80542000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 242542000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 87481000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 162000000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 74519000 | USD | 20230502 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 296852000 | USD | 20240222 | Open filing evidence |
Companion Animal Group Segment · Reference Laboratory Diagnostic And Consulting Services
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ProductOrServiceAxis=idxx:ReferenceLaboratoryDiagnosticAndConsultingServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 344338000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1278617000 | USD | 20240222 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 320294000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 973580000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 323180000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1178113000 | USD | 20240222 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 295590000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 894795000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 295075000 | USD | 20230502 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1123656000 | USD | 20240222 | Open filing evidence |
Companion Animal Group Segment · Systems And Hardware
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ProductOrServiceAxis=idxx:SystemsAndHardwareMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 15349000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 15526000 | USD | 20240501 | Open filing evidence |
Companion Animal Group Segment · Veterinary Software Services And Diagnostic Imaging Systems
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ProductOrServiceAxis=idxx:VeterinarySoftwareServicesAndDiagnosticImagingSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 279328000 | USD | 20240222 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 251187000 | USD | 20240222 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 206258000 | USD | 20240222 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 162976000 | USD | 20230216 | Open filing evidence |
Companion Animal Group Segment · Vetlab Consumables
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ProductOrServiceAxis=idxx:VetlabConsumablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 296042000 | USD | 20231101 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 890891000 | USD | 20231101 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 262820000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 796072000 | USD | 20231101 | Open filing evidence |
Companion Animal Group Segment · Vet Lab Consumables
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:CompanionAnimalGroupSegmentMember;srt:ProductOrServiceAxis=idxx:VetLabConsumablesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 316929000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 291114000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1057236000 | USD | 20230216 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1006781000 | USD | 20230216 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 824376000 | USD | 20230216 | Open filing evidence |
Livestock And Poultry Diagnostics Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:LivestockAndPoultryDiagnosticsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 28992000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 87503000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 30306000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 58511000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 28205000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 121659000 | USD | 20240222 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 29747000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 88866000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 29911000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 59119000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 29208000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 122607000 | USD | 20240222 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 28452000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 89211000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 29889000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 60759000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 30870000 | USD | 20230502 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 135887000 | USD | 20240222 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 145845000 | USD | 20230216 | Open filing evidence |
Lpd Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:LpdSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-07-01 – 2022-09-30 | 28452000 | USD | 20221101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 89211000 | USD | 20221101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 29889000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 60759000 | USD | 20220802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 30870000 | USD | 20220504 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 29126000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 101920000 | USD | 20221101 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 33524000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 72794000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 39270000 | USD | 20220504 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 36971000 | USD | 20211102 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 103369000 | USD | 20211102 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 32244000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 66398000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 34154000 | USD | 20210504 | Open filing evidence |
LPD Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:LPDSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 145845000 | USD | 20210212 | Open filing evidence |
Other Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:OtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 4399000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 12181000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 4248000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 7782000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 3534000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 18789000 | USD | 20240222 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 4170000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 13033000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 4038000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 8863000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 4825000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 30204000 | USD | 20240222 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 7379000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 22878000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 7375000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 15499000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 8124000 | USD | 20230502 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 43008000 | USD | 20240222 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 10657000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 32119000 | USD | 20221101 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 9832000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 21462000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 11630000 | USD | 20220504 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 46420000 | USD | 20230216 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 13529000 | USD | 20211102 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 30698000 | USD | 20211102 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 11132000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 17169000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 6037000 | USD | 20210504 | Open filing evidence |
Other Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:OtherSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 13529000 | USD | 20201029 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 30698000 | USD | 20201029 | Open filing evidence |
Water Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=idxx:WaterSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 50162000 | USD | 20241031 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 139959000 | USD | 20241031 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 46726000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 89797000 | USD | 20240806 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 43071000 | USD | 20240501 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 168149000 | USD | 20240222 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 44450000 | USD | 20241031 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 126362000 | USD | 20241031 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 43029000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 81912000 | USD | 20240806 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 38883000 | USD | 20240501 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 155720000 | USD | 20240222 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 40840000 | USD | 20231101 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 116406000 | USD | 20231101 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 39195000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 75566000 | USD | 20230801 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 36371000 | USD | 20230502 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 146505000 | USD | 20240222 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 38143000 | USD | 20221101 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 109374000 | USD | 20221101 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 37191000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 71231000 | USD | 20220802 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 34040000 | USD | 20220504 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 128625000 | USD | 20230216 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 33272000 | USD | 20211102 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 95537000 | USD | 20211102 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 28116000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 62265000 | USD | 20210730 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 34149000 | USD | 20210504 | Open filing evidence |